Literature DB >> 6266084

Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients.

R H Rubin, A B Cosimi, M S Hirsch, J T Herrin, P S Russell, N E Tolkoff-Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6266084     DOI： 10.1097/00007890-198102000-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

Review 1.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

2.  The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.

Authors:  F L Delmonico; H Auchincloss; R H Rubin; P S Russell; N Tolkoff-Rubin; L T Fang; A B Cosimi
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

3.  A modified vascularized whole knee joint allotransplantation model in the rat.

Authors:  Mikko Larsen; Patricia F Friedrich; Allen T Bishop
Journal:  Microsurgery       Date:  2010-10       Impact factor: 2.425

4.  Activation of cytomegalovirus in pig-to-primate organ xenotransplantation.

Authors:  Nicolas J Mueller; Rolf N Barth; Shin Yamamoto; Hiroshi Kitamura; Clive Patience; Kazuhiko Yamada; David K C Cooper; David H Sachs; Amitinder Kaur; Jay A Fishman
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Detection of cytomegalovirus in peripheral leukocytes by different methods.

Authors:  W Wunderli; M K Kägi; E Grüter; J D Auracher
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

Authors:  J J Fung; A J Demetris; K A Porter; S Iwatsuki; R D Gordon; C O Esquivel; R Jaffe; A Tzakis; B W Shaw; T E Starzl
Journal:  Nephron       Date:  1987       Impact factor: 2.847

7.  Renal graft dysfunction during infection with cytomegalovirus: association with IgM lymphocytotoxins and HLA-DR3 and DR7.

Authors:  W M Baldwin; F H Claas; A van Es; W L Westedt; G van Gemert; M R Daha; L A van Es
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

Review 8.  Cytomegalovirus infection and disease after liver transplantation. An overview.

Authors:  R J Stratta; M S Shaeffer; R S Markin; R P Wood; A N Langnas; E C Reed; J P Donovan; G L Woods; K A Bradshaw; T J Pillen
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

9.  Nonhuman primate infections after organ transplantation.

Authors:  Silke V Haustein; Amanda J Kolterman; Jeffrey J Sundblad; John H Fechner; Stuart J Knechtle
Journal:  ILAR J       Date:  2008

10.  Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study.

Authors:  Viviana Navarro-Rodríguez; Alvaro Herrera-Munoz; Adrián Castro; Allan Ramos-Esquivel
Journal:  J Nephropathol       Date:  2017-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.